BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

NCT02742623 ·Status: COMPLETED

Rivaroxaban Anticoagulation for Superficial Vein Thrombosis

NCT02123524 ·Status: COMPLETED ·Phase: PHASE3

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

NCT05920343 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

NCT00571649 ·Status: COMPLETED ·Phase: PHASE3

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer

NCT00786422 ·Status: COMPLETED ·Phase: PHASE2

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

NCT02746185 ·Status: COMPLETED ·Phase: PHASE3

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

NCT01619007 ·Status: COMPLETED

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

NCT02111564 ·Status: COMPLETED ·Phase: PHASE3

Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data

NCT05264168 ·Status: COMPLETED

Study of Rivaroxaban for CeREbral Venous Thrombosis

NCT03178864 ·Status: COMPLETED ·Phase: PHASE2

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

NCT01583218 ·Status: COMPLETED ·Phase: PHASE3

Follow-up in Rivaroxaban Patients in Setting of Thromboembolism

NCT02248610 ·Status: COMPLETED

Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant

NCT02079584 ·Status: COMPLETED

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

NCT02504216 ·Status: COMPLETED ·Phase: PHASE3

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

NCT00831714 ·Status: COMPLETED

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners

NCT03965741 ·Status: COMPLETED

Xarelto Regulatory Post-Marketing Surveillance

NCT01029743 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

NCT02555878 ·Status: COMPLETED ·Phase: PHASE3

A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department

NCT02584660 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy

NCT02210819 ·Status: COMPLETED

Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

NCT01516814 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

NCT01662908 ·Status: COMPLETED ·Phase: PHASE2

Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism

NCT03091621 ·Status: UNKNOWN

Oral Rivaroxaban in Children With Venous Thrombosis

NCT01684423 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

NCT04444804 ·Status: COMPLETED